A Study of the Safety and Efficacy of Synvisc and Depo-Medrol in Patients With Osteoarthritis of the Hip

Genzyme

Status and phase: Completed; Phase 3

Conditions: Osteoarthritis, Hip; Musculoskeletal Diseases

Treatments: Device: Synvisc (hylan G-F 20)

Study type: Interventional

Funder types: Industry

Identifiers

NCT00131326

SYNV-004-02

Details and patient eligibility

About

This is a clinical study to investigate the safety and efficacy of Synvisc and Depo-Medrol in treating patients with osteoarthritis (OA) of the hip.

Sex: All

Ages: 35+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with symptomatic osteoarthritis pain of hip

Exclusion criteria

• Patients with current or prior conditions or treatment that would impede measurement of efficacy and safety

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind